Success Metrics

Clinical Success Rate
100.0%

Based on 7 completed trials

Completion Rate
100%(7/7)
Active Trials
0(0%)
Results Posted
29%(2 trials)

Phase Distribution

Ph phase_4
3
33%
Ph phase_2
3
33%
Ph phase_1
2
22%

Phase Distribution

2

Early Stage

3

Mid Stage

3

Late Stage

Phase Distribution8 total trials
Phase 1Safety & dosage
2(25.0%)
Phase 2Efficacy & side effects
3(37.5%)
Phase 4Post-market surveillance
3(37.5%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

87.5%

7 of 8 finished

Non-Completion Rate

12.5%

1 ended early

Currently Active

0

trials recruiting

Total Trials

9

all time

Status Distribution
Completed(7)
Terminated(1)
Other(1)

Detailed Status

Completed7
Withdrawn1
unknown1

Development Timeline

Analytics

Development Status

Total Trials
9
Active
0
Success Rate
100.0%
Most Advanced
Phase 4

Trials by Phase

Phase 12 (25.0%)
Phase 23 (37.5%)
Phase 43 (37.5%)

Trials by Status

withdrawn111%
completed778%
unknown111%

Recent Activity

0 active trials
Showing 5 of 9
withdrawnphase_4

Patient Adherence to Premarin Versus Vagifem Therapy After Female Pelvic Reconstructive Surgery

NCT02860897
completedphase_2

Treatment Of Hot Flashes/Flushes In Postmenopausal Women (WARM Study)

NCT00604825
unknownphase_4

Premarin Versus Toviaz for Treatment of Overactive Bladder

NCT01613170
completedphase_4

Effect of Preoperative Estrogen Treatment on Connective Tissues of the Pelvic Floor

NCT01778985
completedphase_2

Two Doses of Conjugated Estrogen (Premarin) in Patients With Androgen-Independent Prostate Cancer

NCT00134654
View all 9 trials

Clinical Trials (9)

Showing 9 of 9 trials
NCT02860897Phase 4

Patient Adherence to Premarin Versus Vagifem Therapy After Female Pelvic Reconstructive Surgery

Withdrawn
NCT00604825Phase 2

Treatment Of Hot Flashes/Flushes In Postmenopausal Women (WARM Study)

Completed
NCT01613170Phase 4

Premarin Versus Toviaz for Treatment of Overactive Bladder

Unknown
NCT01778985Phase 4

Effect of Preoperative Estrogen Treatment on Connective Tissues of the Pelvic Floor

Completed
NCT00134654Phase 2

Two Doses of Conjugated Estrogen (Premarin) in Patients With Androgen-Independent Prostate Cancer

Completed
NCT00318318Phase 1

Beneficial Effects of Oral Premarin Estrogen Replacement Therapy Assessed by Human Genome Array

Completed
NCT00745173Phase 1

Study Evaluating Premarin and Bazedoxifene Potential Interaction

Completed
NCT00234676Phase 2

POETRY: Study of Estrogen Replacement Therapy in Postmenopausal Women With Parkinson's Disease

Completed
NCT00380887

Study Comparing Four New Formulations for Premarin in Healthy Postmenopausal Women

Completed

All 9 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
9